Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Noninvasive 11C-rifampin positron emission tomography reveals drug biodistribution in tuberculous meningitis.

Tucker EW, Guglieri-Lopez B, Ordonez AA, Ritchie B, Klunk MH, Sharma R, Chang YS, Sanchez-Bautista J, Frey S, Lodge MA, Rowe SP, Holt DP, Gobburu JVS, Peloquin CA, Mathews WB, Dannals RF, Pardo CA, Kannan S, Ivaturi VD, Jain SK.

Sci Transl Med. 2018 Dec 5;10(470). pii: eaau0965. doi: 10.1126/scitranslmed.aau0965.

PMID:
30518610
2.

Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation.

Piñana JL, Perez-Pitarch A, Guglieri-Lopez B, Giménez E, Hernandez-Boluda JC, Terol MJ, Ferriols-Lisart R, Solano C, Navarro D.

Am J Transplant. 2018 Dec;18(12):2885-2894. doi: 10.1111/ajt.14754. Epub 2018 Apr 24.

PMID:
29603596
3.

Influenza vaccine effectiveness in preventing hospitalisation of individuals 60 years of age and over with laboratory-confirmed influenza, Valencia Region, Spain, influenza season 2016/17.

Mira-Iglesias A, López-Labrador FX, Guglieri-López B, Tortajada-Girbés M, Baselga-Moreno V, Cano L, Mollar-Maseres J, Carballido-Fernández M, Schwarz-Chavarri G, Díez-Domingo J, Puig-Barberà J; Valencia Hospital Network For The Study Of Influenza And Respiratory Viruses Disease.

Euro Surveill. 2018 Feb;23(8). doi: 10.2807/1560-7917.ES.2018.23.8.17-00318.

4.

Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season.

Puig-Barberà J, Guglieri-López B, Tortajada-Girbés M, López-Labrador FX, Carballido-Fernández M, Mollar-Maseres J, Schwarz-Chavarri G, Baselga-Moreno V, Mira-Iglesias A, Díez-Domingo J; Valencia Hospital Network for the Study of Influenza, Respiratory Viruses Disease.

Vaccine. 2017 Dec 19;35(52):7331-7338. doi: 10.1016/j.vaccine.2017.10.100. Epub 2017 Nov 8.

5.

Dosing of caspofungin based on a pharmacokinetic/pharmacodynamic index for the treatment of invasive fungal infections in critically ill patients on continuous venovenous haemodiafiltration.

Pérez-Pitarch A, Ferriols-Lisart R, Aguilar G, Ezquer-Garín C, Belda FJ, Guglieri-López B.

Int J Antimicrob Agents. 2018 Jan;51(1):115-121. doi: 10.1016/j.ijantimicag.2017.05.013. Epub 2017 Jun 27.

PMID:
28666752
6.

Impact of Undernutrition on the Pharmacokinetics and Pharmacodynamics of Anticancer Drugs: A Literature Review.

Pérez-Pitarch A, Guglieri-López B, Nacher A, Merino V, Merino-Sanjuán M.

Nutr Cancer. 2017 May-Jun;69(4):555-563. doi: 10.1080/01635581.2017.1299878. Epub 2017 Mar 29. Review.

PMID:
28353359
7.

Levofloxacin effect on erlotinib absorption. Evaluation of the interaction in undernutrition situations through population pharmacokinetic analysis in rats.

Pérez-Pitarch A, Guglieri-López B, Nacher A, Merino V, Merino-Sanjuan M.

Biopharm Drug Dispos. 2017 Jul;38(5):315-325. doi: 10.1002/bdd.2065. Epub 2017 Feb 17.

PMID:
28099756
8.

Population pharmacokinetics of lenalidomide in multiple myeloma patients.

Guglieri-López B, Pérez-Pitarch A, Moes DJ, Porta-Oltra B, Climente-Martí M, Guchelaar HJ, Merino-Sanjuán M.

Cancer Chemother Pharmacol. 2017 Jan;79(1):189-200. doi: 10.1007/s00280-016-3228-y. Epub 2016 Dec 30.

PMID:
28039509
9.

Effectiveness, toxicity, and economic evaluation of ipilimumab for the treatment of patients with metastatic melanoma in the Spanish outpatient setting.

Guglieri-López B, Pérez-Pitarch A, Porta Oltra B, Ferriols-Lisart F, Royo-Peiró Á, Climente-Martí M.

Anticancer Drugs. 2016 Aug;27(7):679-84. doi: 10.1097/CAD.0000000000000368.

PMID:
27058705
10.

A Wide Linearity Range Method for the Determination of Lenalidomide in Plasma by High-Performance Liquid Chromatography: Application to Pharmacokinetic Studies.

Guglieri-López B, Pérez-Pitarch A, Martinez-Gómez MA, Porta-Oltra B, Climente-Martí M, Merino-Sanjuán M.

J Lab Autom. 2016 Dec;21(6):806-810. Epub 2016 Mar 8.

PMID:
26956578
11.

A model-based meta-analysis of sofosbuvir-based treatments in chronic hepatitis C patients.

Pérez-Pitarch A, Guglieri-López B, Ferriols-Lisart R, Merino-Sanjuán M.

Int J Antimicrob Agents. 2016 Mar;47(3):184-94. doi: 10.1016/j.ijantimicag.2015.12.008. Epub 2016 Jan 12.

PMID:
26915476
12.

Effectiveness, toxicity, and economic evaluation of vinflunine for the treatment of patients with transitional cell carcinoma in the Spanish outpatient setting.

Guglieri-López B, Pérez-Pitarch A, Porta-Oltra B, Ferriols-Lisart F, Climente-Martí M, Alós-Almiñana M.

Anticancer Drugs. 2015 Sep;26(8):860-5. doi: 10.1097/CAD.0000000000000240.

PMID:
25919319
13.

[Incidence, management and costs of adverse effects in chronic hepatitis C patients on triple therapy with telaprevir or boceprevir: first 12 weeks of treatment].

Guglieri-López B, Ventura-Cerdá JM, Gómez-Álvarez S, Climente-Martí M.

Enferm Infecc Microbiol Clin. 2015 May;33(5):331-6. doi: 10.1016/j.eimc.2014.05.012. Epub 2014 Aug 13. Spanish.

PMID:
25128462
14.

[Eltrombopag for the treatment of thrombocytopenia in patients with chronic hepatitis C: two case reports].

Guglieri-López B, Ventura-Cerdá JM, Carmena-Carmena J, Climente-Mónica M.

Farm Hosp. 2013 Sep-Oct;37(5):419-21. doi: 10.7399/FH.2013.37.5.733. Spanish. No abstract available.

Supplemental Content

Loading ...
Support Center